Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

What is Cancer?

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

New Insights into the Development of Papillary Thyroid Cancer: The Roles of miR-1179 and ELF3.

Cells·2026

Same author

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy.

British journal of cancer·2026

Same author

<i>Dicer1</i> Depletion Leads to DNA Damage Accumulation and Cell Death in a RET/PTC3 Papillary Thyroid Cancer Mouse Model, Thereby Inhibiting Tumor Progression.

Cells·2025

Same author

Systematic analysis of A-to-I RNA editing upon release of ADAR from the nucleolus.

RNA biology·2025

Same author

HMGA2 Overexpression in Papillary Thyroid Cancer Promotes Thyroid Cell Dedifferentiation and Invasion, and These Effects Are Counteracted by Suramin.

International journal of molecular sciences·2025

Same author

Population-based, first-tier genomic newborn screening in the maternity ward.

Nature medicine·2025

Search research articles

Related Experiment Video

Updated: Oct 6, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications.

Valerie Jacquemin¹, Mathieu Antoine¹, Geneviève Dom¹

¹Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, 1070 Brussels, Belgium.

|January 21, 2022

Summary

Cancer is a dynamic, heterogeneous cooperative cell population, not distinct entities. Understanding this evolving heterogeneity is crucial for accurate diagnosis and effective cancer treatment strategies.

Keywords:

heterogeneity implication molecular level thyroid cancer tumor ecosystem

More Related Videos

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Published on: June 30, 2017

Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture

Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture

Published on: June 23, 2020

Related Experiment Videos

Last Updated: Oct 6, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Published on: June 30, 2017

Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture

Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture

Published on: June 23, 2020

Area of Science:

Oncology
Cell Biology
Pathology

Background:

Cancer is often viewed as distinct entities, overlooking its inherent cellular heterogeneity.
This overlooks the concept of cancer as a dynamic, heterogeneous cooperative cell population with its own biology.
Existing literature and routine examinations frequently neglect the dynamic nature of cancer heterogeneity.

Purpose of the Study:

To summarize and discuss the multifaceted aspects of cancer's dynamic evolving heterogeneity.
To highlight the biological, pathological, clinical, diagnostic, and therapeutic implications of cancer heterogeneity.
To use thyroid carcinoma as a specific example to illustrate these implications.

Main Methods:

Review of current literature on cancer heterogeneity.
Analysis of conceptual gaps in understanding cancer as a cooperative cell population.
Case study using thyroid carcinoma to exemplify heterogeneity's impact.

Main Results:

Cancer's heterogeneity is a dynamic, evolving process, not static distinct entities.
Conceptual gaps in understanding heterogeneity can lead to misinterpretations in diagnosis and therapy.
Thyroid carcinoma serves as a model to demonstrate the clinical and diagnostic relevance of heterogeneity.

Conclusions:

Recognizing cancer as a heterogeneous cooperative cell population is essential.
Addressing the dynamic nature of cancer heterogeneity can improve diagnostic and therapeutic approaches.
Further research into cancer's evolving heterogeneity is critical for advancing oncology.